Readibility testing of Package Information Leaflets
All medicinal products placed on the European Community market are
required by Community law to be accompanied by labelling and package
leaflet which provide a set of comprehensible information enabling the
use of the medicinal product safely and appropriately.
Directive 2001/83/EC provides that the package leaflet shall reflect
the results of consultations with target patient groups to ensure that
it is legible, clear and easy to use. Goodwill Research Ltd. is eagerly
offering its help undertaking user tests of package leaflets with a
methodology compliant to international guidelines. Based on results of
the user testing we recommend leaflet text and/or layout changes.